2,524 results on '"Herrmann Nathan"'
Search Results
52. Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia
53. The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer’s disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status
54. Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease
55. Investigating the safety and efficacy of nabilone for the treatment of agitation in patients with moderate-to-severe Alzheimer's disease: Study protocol for a cross-over randomized controlled trial
56. Future Directions for Geriatric Anesthesiology
57. The Roles of Apathy and Depression in Predicting Alzheimer Disease: A Longitudinal Analysis in Older Adults With Mild Cognitive Impairment
58. Time setting errors in the Clock Drawing Test are associated with both semantic and executive deficits.
59. About time: neurocognitive correlates of stimulus-bound and other time setting errors in the Clock Drawing Test
60. Neuroticism is associated with entorhinal cortex volume in cognitively unimpaired older adults
61. Changes in Brain Glutathione in patients with mild vascular cognitive impairment
62. Investigating the effects of aerobic exercise primed anodal transcranial direct current stimulation on γ‐aminobutyric acid concentrations in mild vascular cognitive impairment
63. Beta to Theta Power Ratio in Electroencephalogram Periodic Components to Discriminate Mild Cognitive Impairment and Alzheimer’s Dementia
64. Brain glutathione may be associated with white matter hyperintensities in patients with cardiovascular disease
65. Fluid Biomarkers of Neurodegeneration in Mild Cognitive Impairment: A Meta‐Analysis
66. FC44: Prevalence of mental health outcomes and the impact of sex and mood or cognitive comorbidity in older adults during the COVID-19 pandemic
67. Investigating the impact of hypertension with and without diabetes on progression to Alzheimer’s disease: A clinic‐pathological study
68. Risk of motor vehicle collisions and culpability among older drivers using cannabis: a meta‐analysis
69. ASSOCIATION BETWEEN MOTOR ACTIVITY AND TOTAL NEUROPSYCHIATRIC INVENTORY NURSING HOME VERSION SCORES
70. Comparing the distribution of neuropsychiatric symptoms among individuals with depression and mild cognitive impairment
71. Blood‐based biomarkers for predicting treatment response in the Apathy in Dementia Methylphenidate Trial 2 randomized clinical trial
72. Circulating cell‐free mitochondrial DNA (ccf‐mtDNA) and memory in mild cognitive impairment (MCI) and Alzheimer’s disease (AD)
73. Association between lipopolysaccharide, immune biomarkers and cerebral amyloid‐beta deposition in older adults with mild cognitive impairment & major depressive disorder
74. Longitudinal associations between 4-hydroxynonenal and depression in coronary artery disease patients
75. Predictors of Cholinesterase Discontinuation during the First Year after Nursing Home Admission
76. Biomarkers of agitation and aggression in Alzheimer's disease: A systematic review
77. The effect of exercise on resting concentrations of peripheral brain-derived neurotrophic factor (BDNF) in major depressive disorder: A meta-analysis
78. APOE-ε4 associates with hippocampal volume, learning, and memory across the spectrum of Alzheimer's disease and dementia with Lewy bodies
79. Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression
80. Age representation in antiepileptic drug trials: A systematic review and meta-analysis
81. Suicide deaths by intentional self-poisoning in people with cardiovascular disease
82. Depression and Diabetes Mellitus Multimorbidity Is Associated With Loss of Independence and Dementia Poststroke
83. Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future.
84. Sex Differences in the Prevalent Use of Oral Formulations of Cholinesterase Inhibitors in Older Adults with Dementia
85. Novel Pharmacologic Strategies for Treating Behavioral Disturbances in Alzheimer’s Disease
86. Current Agents in Development for Treating Behavioral and Psychological Symptoms Associated with Dementia
87. Global grey matter volume in adult bipolar patients with and without lithium treatment: A meta-analysis
88. Pharmacotherapy of Dementia
89. Evidence for Inflammation-Associated Depression
90. Examining the sex-specific association between APOE ε4 status and increased neuropsychiatric symptom burden in populations at risk for Alzheimer's disease
91. Self- versus informant-report of cognitive decline in mild cognitive impairment: Concordance with cognitive and functional performance.
92. No association between metformin initiation and incident dementia in older adults newly diagnosed with diabetes
93. Age-Related Alterations in Gray Matter Microstructure in Older People With Remitted Major Depression at Risk for Dementia
94. Peripheral lipid oxidative stress markers are related to vascular risk factors and subcortical small vessel disease
95. C-reactive protein and cardiovascular risk in bipolar disorder patients: A systematic review
96. Ceramides and depression: A systematic review
97. Evidence-based umbrella review of 162 peripheral biomarkers for major mental disorders
98. Attentional impairments to novel images in dementia
99. Contributors
100. Pharmacological Interventions for Cognitive Dysfunction in Major Depressive Disorder
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.